Huiyu Pharmaceutical: Shareholder Intends to Reduce No More Than 3% of the Company's Shares

MetaMuskRat · 2026-03-18T10:02:17+00:00

People Finance News March 16 — Huiyu Pharmaceutical (688553) announced on March 16 that shareholder Wang Xiaopeng, holding 3.94% of shares, plans to reduce holdings of no more than 12.708 million shares of the company through a combination of centralized competitive bidding and block trades due to personal capital needs, with a total reduction ratio not exceeding 3% of the company's total shares.

MetaMuskRat

2026-03-18 10:02:17

People’s Financial News, March 16 — Huiyu Pharmaceutical (688553) announced on March 16 that shareholder Wang Xiaopeng, who owns 3.94% of the shares, plans to reduce his holdings by a total of no more than 12,708,000 shares through centralized bidding and block trades due to personal funding needs. The total reduction will not exceed 3% of the company’s total shares.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.